A Third SARS-CoV-2 mRNA Vaccine Dose in People Receiving Hemodialysis Overcomes B Cell Defects but Elicits a Skewed CD4⁺ T Cell Profile

The authors longitudinally analyze antibody, B cell, CD4+, and CD8+ T cell vaccine responses in 27 hemodialysis patients and 26 low-risk control individuals.